Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The Food and Drug Administration was set to release new guidance on COVID booster shots ahead of the fall season, but that's ...

Dr. Marty Makary had just finished his last surgery at Johns Hopkins when he stepped into one of the most powerful roles in ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

Novavax's COVID vaccine was approved under an emergency use authorization in August 2022, and the company has pursued full ...